| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Immunology, The Scripps Research Institute, La Jolla, California 92037
Previously, we reported that urokinase-type plasminogen activator (uPA) plays a pivotal role in extracellular matrix dissolution by malignant melanoma cells. Here, we demonstrate that a highly metastatic melanoma cell line (M24met) that secretes uPA expresses high levels of the uPA receptor (uPAR), 2.4 x 106 binding sites/cell with a KD of 5.67 x 10-10 M. The receptor was identified as a 55,00060,000 kDa cell surface protein. Although M24met cells secrete uPA, they are unable to efficiently utilize this enzyme for invasion, unless it is bound to its receptor. This contention is based on the finding that an antibody against uPAR (monoclonal antibody 3936) inhibited invasion of M24met cells through a reconstituted basement membrane (Matrigel) up to 33%, while a reduction of uPA catalytic activity by its plasminogen activator inhibitor-2 resulted in 46% inhibition of invasion. Furthermore, uPAR is involved in signal transduction events in M24met cells, since both uPA and its amino-terminal fragment stimulated the migration of melanoma cells toward Matrigel, resulting in maximal increases of 32 and 72%, respectively. Our results indicate that both uPA and uPAR are involved in melanoma metastasis and that uPAR contributes to at least two important steps in this process, matrix dissolution and migration.
1 Data presented in this publication were obtained by A.S. as part of his doctoral thesis to be submitted to the Faculty of Biology at the University of Hamburg. This is The Scripps Research Institute manuscript 8370-IMM.
2 Recipient of a fellowship from the Studienstiftung des Deutschen Volkes.
3 To whom requests for reprints should be addressed, at Department of Immunology, The Scripps Research Institute, 10666 N. Torrey Pines Road, La Jolla, CA 92037.
Received 12/13/93. Accepted 4/ 5/94.
This article has been cited by other articles:
![]() |
J.-W. Liu, P. Sun, Q. Yan, A. S. Paller, P. Gerami, N. Ho, N. Vashi, I. C. Le Poole, and X.-q. Wang De-N-acetyl GM3 Promotes Melanoma Cell Migration and Invasion through Urokinase Plasminogen Activator Receptor Signaling-Dependent MMP-2 Activation Cancer Res., November 15, 2009; 69(22): 8662 - 8669. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Kwak, M.-J. Park, H. Cho, C.-M. Park, S.-I. Moon, H.-C. Lee, I.-C. Park, M.-S. Kim, C. H. Rhee, and S.-I. Hong Transforming Growth Factor-{beta}1 Induces Tissue Inhibitor of Metalloproteinase-1 Expression via Activation of Extracellular Signal-Regulated Kinase and Sp1 in Human Fibrosarcoma Cells Mol. Cancer Res., March 1, 2006; 4(3): 209 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Gondi, S. S. Lakka, N. Yanamandra, W. C. Olivero, D. H. Dinh, M. Gujrati, C. H. Tung, R. Weissleder, and J. S. Rao Adenovirus-Mediated Expression of Antisense Urokinase Plasminogen Activator Receptor and Antisense Cathepsin B Inhibits Tumor Growth, Invasion, and Angiogenesis in Gliomas Cancer Res., June 15, 2004; 64(12): 4069 - 4077. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Chand, X. Du, D. Ma, H. D. Inzunza, S. Kamei, D. Foster, S. Brodie, and W. Kisiel The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice Blood, February 1, 2004; 103(3): 1069 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Leake, T. D. Doerr, and G. Scott Expression of Urokinase-type Plasminogen Activator and Its Receptor in Keloids Arch Otolaryngol Head Neck Surg, December 1, 2003; 129(12): 1334 - 1338. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Lakka, C. S. Gondi, N. Yanamandra, D. H. Dinh, W. C. Olivero, M. Gujrati, and J. S. Rao Synergistic Down-Regulation of Urokinase Plasminogen Activator Receptor and Matrix Metalloproteinase-9 in SNB19 Glioblastoma Cells Efficiently Inhibits Glioma Cell Invasion, Angiogenesis, and Tumor Growth Cancer Res., May 15, 2003; 63(10): 2454 - 2461. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Koolwijk, N. Sidenius, E. Peters, C. F. M. Sier, R. Hanemaaijer, F. Blasi, and V. W. M. van Hinsbergh Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices Blood, May 15, 2001; 97(10): 3123 - 3131. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ferland, M. Guilbert, F. Davoine, N. Flamand, J. Chakir, and M. Laviolette Eotaxin promotes eosinophil transmigration via the activation of the plasminogen-plasmin system J. Leukoc. Biol., May 1, 2001; 69(5): 772 - 778. [Abstract] [Full Text] |
||||
![]() |
C. Foca, E.K. Moses, M.A. Quinn, and G.E. Rice Differential expression of the {alpha}2-macroglobulin receptor and the receptor associated protein in normal human endometrium and endometrial carcinoma Mol. Hum. Reprod., October 1, 2000; 6(10): 921 - 927. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. HAJ-YEHIA, T. NASSAR, B. S. SACHAIS, A. KUO, K. BDEIR, A. B. AL-MEHDI, A. MAZAR, D. B. CINES, and A. A.-R. HIGAZI Urokinase-derived peptides regulate vascular smooth muscle contraction in vitro and in vivo FASEB J, July 1, 2000; 14(10): 1411 - 1422. [Abstract] [Full Text] |
||||
![]() |
H. Shiomi, Y. Eguchi, T. Tani, M. Kodama, and T. Hattori Cellular Distribution and Clinical Value of Urokinase-Type Plasminogen Activator, Its Receptor, and Plasminogen Activator Inhibitor-2 in Esophageal Squamous Cell Carcinoma Am. J. Pathol., February 1, 2000; 156(2): 567 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Webb, D. Nguyen, and S. Gonias Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion J. Cell Sci., January 1, 2000; 113(1): 123 - 134. [Abstract] [PDF] |
||||
![]() |
U. Benbow, M. P. Schoenermark, T. I. Mitchell, J. L. Rutter, K.-i. Shimokawa, H. Nagase, and C. E. Brinckerhoff A Novel Host/Tumor Cell Interaction Activates Matrix Metalloproteinase 1 and Mediates Invasion through Type I Collagen J. Biol. Chem., September 3, 1999; 274(36): 25371 - 25378. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Xing and S. A. Rabbani Regulation of Urokinase Production by Androgens in Human Prostate Cancer Cells: Effect on Tumor Growth and Metastases in Vivo Endocrinology, September 1, 1999; 140(9): 4056 - 4064. [Abstract] [Full Text] |
||||
![]() |
M. Guilbert, C. Ferland, M. Bossé, N. Flamand, S. Lavigne, and M. Laviolette 5-Oxo-6,8,11,14-Eicosatetraenoic Acid Induces Important Eosinophil Transmigration through Basement Membrane Components . Comparison of Normal and Asthmatic Eosinophils Am. J. Respir. Cell Mol. Biol., July 1, 1999; 21(1): 97 - 104. [Abstract] [Full Text] |
||||
![]() |
G Cox, W P Steward, and K J O'Byrne The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer Thorax, February 1, 1999; 54(2): 169 - 179. [Full Text] |
||||
![]() |
N Nayeem, S Silletti, X Yang, V. Lemmon, R. Reisfeld, W. Stallcup, and A. Montgomery A potential role for the plasmin(ogen) system in the posttranslational cleavage of the neural cell adhesion molecule L1 J. Cell Sci., January 12, 1999; 112(24): 4739 - 4749. [Abstract] [PDF] |
||||
![]() |
S Suzuki, Y Hayashi, Y Wang, T Nakamura, Y Morita, K Kawasaki, K Ohta, N Aoyama, S R Kim, H Itoh, et al. Urokinase type plasminogen activator receptor expression in colorectal neoplasms Gut, December 1, 1998; 43(6): 798 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Ferrier, W. L. van Geloof, H. H. de Witte, M. D. Kramer, D. J. Ruiter, and G. N.P. van Muijen Epitopes of Components of the Plasminogen Activation System are Re-exposed in Formalin-fixed Paraffin Sections by Different Retrieval Techniques J. Histochem. Cytochem., April 1, 1998; 46(4): 469 - 476. [Abstract] [Full Text] |
||||
![]() |
J.-M. Herbert, I. Lamarche, and P. Carmeliet Urokinase and Tissue-type Plasminogen Activator Are Required for the Mitogenic and Chemotactic Effects of Bovine Fibroblast Growth Factor and Platelet-derived Growth Factor-BB for Vascular Smooth Muscle Cells J. Biol. Chem., September 19, 1997; 272(38): 23585 - 23591. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yu, J. Kim, and L. Ossowski Reduction in Surface Urokinase Receptor Forces Malignant Cells into a Protracted State of Dormancy J. Cell Biol., May 5, 1997; 137(3): 767 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Bonavaud, C Charriere-Bertrand, C Rey, M. Leibovitch, N Pedersen, E Frisdal, E Planus, F Blasi, R Gherardi, and G Barlovatz-Meimon Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion J. Cell Sci., January 5, 1997; 110(9): 1083 - 1089. [Abstract] [PDF] |
||||
![]() |
M. Yebra, G. C.N. Parry, S. Stromblad, N. Mackman, S. Rosenberg, B. M. Mueller, and D. A. Cheresh Requirement of Receptor-bound Urokinase-type Plasminogen Activator for Integrin alpha vbeta 5-directed Cell Migration J. Biol. Chem., November 15, 1996; 271(46): 29393 - 29399. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Okada, S. R. Grobmyer, and E. S. Barnathan Contrasting Effects of Plasminogen Activators, Urokinase Receptor, and LDL Receptor–Related Protein on Smooth Muscle Cell Migration and Invasion Arterioscler Thromb Vasc Biol, October 1, 1996; 16(10): 1269 - 1276. [Abstract] [Full Text] |
||||
![]() |
S. Ghosh, R. Brown, J. C. R. Jones, S. M. Ellerbroek, and M. S. Stack Urinary-type Plasminogen Activator (uPA) Expression and uPA Receptor Localization Are Regulated by alpha 3beta 1 Integrin in Oral Keratinocytes J. Biol. Chem., July 28, 2000; 275(31): 23869 - 23876. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pucci, G. Fibbi, L. Magnelli, and M. Del Rosso Regulation of Urokinase/Urokinase Receptor Interaction by Heparin-like Glycosaminoglycans J. Biol. Chem., February 9, 2001; 276(7): 4756 - 4765. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |